アーカンソー州における統合失調症の臨床試験
アーカンソー州内の拠点で、統合失調症に関する21件の研究が参加者を募集しています。
アーカンソー州内の都市
公式研究テキスト（英語）
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
- Vanda Investigational Site, Little Rock
被験者募集中第4相
12歳〜17歳 · 全性別 · 2026/10/01更新 · NCT05648591Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
- Pillar Clinical Research - Bentonville, Bentonville
- Pillar Clinical Research- Little Rock, Little Rock
- Local Institution - 0021, Little Rock
- 他1件
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/09/28更新 · NCT07686263Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Pillar Clinical Research, LLC, Little Rock
被験者募集中第3相
5歳〜17歳 · 全性別 · 2026/09/25更新 · NCT06229210NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Little Rock
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/09/25更新 · NCT07105098NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Neurocrine Clinical Site, Bryant
- Neurocrine Clinical Site, Little Rock
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/09/25更新 · NCT07114874Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia
- TG Therapeutics Investigational Trial Site, Little Rock
被験者募集中第2相
18歳〜60歳 · 全性別 · 2026/09/23更新 · NCT07680946A Study of Brenipatide in Adult Participants With Schizophrenia
- Pillar Clinical Research- Little Rock, Little Rock
被験者募集中第2相
18歳〜55歳 · 全性別 · 2026/09/22更新 · NCT07410507A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Bryant
被験者募集中第4相
18歳以上 · 全性別 · 2026/09/18更新 · NCT07105111A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
- Pillar Clinical Research, LLC, Little Rock
被験者募集中第1相
18歳〜55歳 · 全性別 · 2026/09/17更新 · NCT07734493A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
- Woodland International Research Group /ID# 275747, Little Rock
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/09/15更新 · NCT0714591852-week Open Label Safety-Tolerability Study
- Pillar Clinical Research, Bentonville
- Pillar Clinical Research, Little Rock
- Woodland International Research Group, Little Rock
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/09/09更新 · NCT07369154A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Little Rock
- Clinical Site, Little Rock
- Clinical Site, Rogers
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/09/01更新 · NCT07459647Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
- SanRo Clinical Research Group, Bryant
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/19更新 · NCT07379827Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
- Alkermes Investigator Site, Little Rock
被験者募集中第3相
10歳〜17歳 · 全性別 · 2026/08/14更新 · NCT05303064Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
- Pillar Clinical Research LLC, Bentonville
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/07/29更新 · NCT07467993Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
- Pillar Clinical Research, Bentonville
- Pillar Clinical Research, Little Rock
- Woodland International Research Group, Little Rock
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/07/27更新 · NCT07363577A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
- Woodland International Research Group, Little Rock
被験者募集中第2相
18歳〜55歳 · 全性別 · 2026/06/23更新 · NCT07191483A Study to Evaluate the Effect of KarXT on Urological Safety
- Pillar Clinical Research- Little Rock, Little Rock
被験者募集中第4相
18歳〜65歳 · 全性別 · 2026/06/03更新 · NCT07221877NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Bryant
- Neurocrine Clinical Site, Little Rock
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/03/06更新 · NCT06963034Randomized Withdrawal Study in Patients With Schizophrenia
- Vanda Investigational Site, Rogers
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/01/12更新 · NCT06961968Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
- Reviva site, Bentonville
- Reviva site, Little Rock
- Reviva site, Rogers
被験者募集中第3相健康なボランティア歓迎
18歳〜65歳 · 全性別 · 2024/12/19更新 · NCT05184335ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。